Clinical Trial Update: Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating guided treatment using mini-PDX in metastatic triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN